Serum cytokine levels in breast cancer patients during neoadjuvant treatment with bevacizumab

A high concentration of circulating vascular endothelial growth factor (VEGF) in cancer patients is associated with an aggressive tumor phenotype. Here, serum levels of 27 cytokines and blood cell counts were assessed in breast cancer patients receiving neoadjuvant chemotherapy with or without bevac...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Shakila Jabeen, Manuela Zucknick, Marianne Nome, Ruth Dannenfelser, Thomas Fleischer, Surendra Kumar, Torben Lüders, Hedda von der Lippe Gythfeldt, Olga Troyanskaya, Jon Amund Kyte, Anne-Lise Børresen-Dale, Bjørn Naume, Xavier Tekpli, Olav Engebraaten, Vessela Kristensen
Format:	Artigo
Jezik:	Inglês
Izdano:	Taylor & Francis Group 2018-11-01
Serija:	OncoImmunology
Teme:	bevacizumab vegf-a neoadjuvant cytokines immunity
Online dostop:	http://dx.doi.org/10.1080/2162402X.2018.1457598
Oznake:	Označite Brez oznak, prvi označite!